Pulse Therapeutics, Inc.

Biotechnology company · St. Louis, Missouri, United States

Pulse Therapeutics, Inc. is a biotechnology company headquartered in St. Louis, Missouri, United States. Its earliest recorded incorporation is in 2008. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $4.9 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $5.6 million sold in a notice filed in 2016.

Profile compiled from public records. Is this your company? Request a correction or update

Pulse Therapeutics at a glance

Typebiotechnology company
HeadquartersSt. Louis, Missouri, United States
Earliest incorporation on record2008
Employees (per SBIR records)5
SEC CIK1518707

What does Pulse Therapeutics do?

US government research funding

6 SBIR/STTR small-business research awards from US health agencies, $4.9 million in total (2014 to 2021). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Institute on Minority Health and Health Disparities.

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $5.6 million sold (2016).

Frequently asked questions about Pulse Therapeutics

Where is Pulse Therapeutics headquartered?

Pulse Therapeutics, Inc. is headquartered in St. Louis, Missouri, United States.

What does Pulse Therapeutics do?

Pulse Therapeutics, Inc. is a biotechnology company.

When was Pulse Therapeutics founded?

The earliest incorporation on record for Pulse Therapeutics, Inc. is in 2008, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.